Baxter International | BAX - Net Income


Baxter International reported $126M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 8.96M 8.85M Jun/2026
Baxter International USD 126M 141M Jun/2026
Becton, Dickinson and Co. USD 377M 688M Jun/2026
Boston Scientific USD 907M 434M Jun/2026
Cooper Companies USD 432.8M 510.7M Jun/2026
Dexcom USD 249.1M 49.6M Jun/2026
Edwards Lifesciences USD 241.9M 138.8M Jun/2026
Fresenius EUR 382M 53M Jun/2026
Globus Medical USD 151.57M 27.27M Jun/2026
Halozyme Therapeutics USD 229.91M 79.86M Jun/2026
ICU Medical USD 19.09M 11.04M Jun/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 95M 3.9M Jun/2026
Integra LifeSciences USD 4.48M 9.1M Jun/2026
Intuitive Surgical USD 818.1M 3.4M Jun/2026
J&J USD 5.53B 299M Jun/2026
Laboratory Of America USD 298.7M 20.9M Jun/2026
Medtronic USD 1.47B 227M Jun/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Quest Diagnostics USD 320M 69M Jun/2026
Smith & Nephew USD 303M 10M Jun/2026
Stryker USD 1.28B 531M Jun/2026
Tandem Diabetes Care USD -21.17M 775K Jun/2026
Teleflex USD 99.69M 107.85M Jun/2026
Terumo JPY 70.43B 44.06B Jun/2026
Zimmer Biomet Holdings USD 198.3M 39.8M Jun/2026